NEK8 and cystic kidney disease: CDK inhibitors, particularly roscovitine, have demonstrated efficacy in targeting dysregulated cell cycle progression, effectively arresting kidney volume expansion and cyst progression in jck/Nek8/Nphp9 mouse models and attenuating renal cyst progression in Cep164-knockout mice [22].